Two exciting new drugs that can dramatically lower “bad” cholesterol levels have received approval from an FDA advisory panel, moving the drugs closer to being available for patient use.
Researchers continue to uncover ways genes influence or cause heart disease. But how best to use this information is not always clear.
Two breakthroughs may get FDA approval in 2015: PCSK9 inhibitors, which can lower cholesterol without statins, and LCZ696, which may better treat heart failure.
Statins lower bad cholesterol and heart disease risk, but it takes more than medication to keep your heart healthy. Lifestyle plays a role, too. Here's what you need to know.
While the benefits of statin use in people with aortic aneurysm disease are not clearly proven, some evidence supports its use. Read further to find out more. It may be worth a discussion with your doctor.
Inflammation doesn’t just occur with injury or infection, but can also affect your heart. It’s a driver for coronary heart disease, and is measured with a simple blood test. Statins may even reduce inflammation. Learn more.
Statin intolerance is a problem for some patients, but there's hope in a new class of LDL-lowering drugs. Latest research results presented at annual cardiology conference show promise.
A recent study found patients with advanced peripheral arterial disease who took statins were half as likely to suffer heart attacks and strokes compared with patients not taking statins. Death rates also were cut in half.
People with diabetes are more likely to develop heart disease. Clouding this issue, the FDA recently issued a warning that statin therapy may be associated with an increased risk of developing diabetes. What gives?